Immunomodulatory Effects of Genetic Alterations Affecting the Kynurenine Pathway

by Fanni A. Boros, László Vécsei, László Vécsei, László Vécsei
Published 2019-11-01

Monitoring the Redox Status in Multiple Sclerosis

by Masaru Tanaka, László Vécsei
Published 2020-10-01

Editorial of Special Issue “Crosstalk between Depression, Anxiety, and Dementia: Comorbidity in Behavioral Neurology and Neuropsychiatry”

by Masaru Tanaka, László Vécsei
Published 2021-05-01

Non-invasive Brain Stimulation in Alzheimer's Disease and Mild Cognitive Impairment—A State-of-the-Art Review on Methodological Characteristics and Stimulation Parameters

by Adrienn Holczer, Viola Luca Németh, Teodóra Vékony, László Vécsei, László Vécsei, László Vécsei, Péter Klivényi, Anita Must, Anita Must
Published 2020-05-01

Kynurenines and Neurofilament Light Chain in Multiple Sclerosis

by Dániel Pukoli, Dániel Pukoli, Helga Polyák, Cecilia Rajda, László Vécsei, László Vécsei
Published 2021-05-01

Searching for Peripheral Biomarkers in Neurodegenerative Diseases: The Tryptophan-Kynurenine Metabolic Pathway

by Nóra Török, Masaru Tanaka, László Vécsei
Published 2020-12-01

Kynurenines and other novel therapeutic strategies in the treatment of dementia

by Zsófia Majláth, János Tajti, László Vécsei
Published 2013-11-01

Exploring the Etiological Links behind Neurodegenerative Diseases: Inflammatory Cytokines and Bioactive Kynurenines

by Masaru Tanaka, József Toldi, László Vécsei
Published 2020-03-01

Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism

by Masaru Tanaka, Zsuzsanna Bohár, László Vécsei
Published 2020-01-01

Mitochondria, Oxidative Stress and the Kynurenine System, with a Focus on Ageing and Neuroprotection

by Katalin Sas, Elza Szabó, László Vécsei
Published 2018-01-01

Exploiting the Therapeutic Potential of Endogenous Immunomodulatory Systems in Multiple Sclerosis—Special Focus on the Peroxisome Proliferator-Activated Receptors (PPARs) and the K...

by Bernadett Fakan, Levente Szalardy, Laszlo Vecsei
Published 2019-01-01

Natural Molecules and Neuroprotection: Kynurenic Acid, Pantethine and α-Lipoic Acid

by Fanni Tóth, Edina Katalin Cseh, László Vécsei
Published 2021-01-01

The effect of emotion and reward contingencies on relational memory in major depression: an eye-movement study with follow-up

by Viola Luca Nemeth, Gergo Csete, Gergely Drotos, Nora Greminger, Zoltan Janka, Laszlo Vecsei, Laszlo Vecsei, Anita Must
Published 2016-11-01

A New Division of Schizophrenia Revealed Expanded Bilateral Brain Structural Abnormalities of the Association Cortices

by István Szendi, Nikoletta Szabó, Nóra Domján, Zsigmond Tamás Kincses, András Palkó, László Vécsei, László Vécsei, Mihály Racsmány
Published 2017-07-01

Therapeutic Approaches for Peripheral and Central Neuropathic Pain

by Délia Szok, János Tajti, Aliz Nyári, László Vécsei
Published 2019-01-01

Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives

by Tamás Biernacki, Dániel Sandi, Krisztina Bencsik, László Vécsei
Published 2020-06-01

PACAP and its role in primary headaches

by Lars Edvinsson, János Tajti, Levente Szalárdy, László Vécsei
Published 2018-03-01

Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations

by Zsuzsanna Bohár, József Toldi, Ferenc Fülöp, László Vécsei
Published 2015-04-01

Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System

by Cecilia Rajda, Zsófia Majláth, Dániel Pukoli, László Vécsei
Published 2015-08-01

Treatment of Chronic Migraine with OnabotulinumtoxinA: Mode of Action, Efficacy and Safety

by Délia Szok, Anett Csáti, László Vécsei, János Tajti
Published 2015-07-01